Luminex (LMNX +5%) pops on a UBS upgrade to Buy on valuation. UBS thinks the stock has been...

|About: Luminex Corporation (LMNX)|By:, SA News Editor

Luminex (LMNX +5%) pops on a UBS upgrade to Buy on valuation. UBS thinks the stock has been oversold recently on the back of its dilutive acquisition GenturaDx, plus negative press over its Biowatch sensors. The investment bank said in a note to clients it sees multiple expansion through launches, and that a high percentage of recurring revenues and a focus on clinical markets "makes for a favorable profile amidst macro challenges.